A. Yaïci

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

Marc Humbert, Olivier Sitbon, A. Yaïci et al. · European Respiratory Journal · 2010 · 670 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an <i>ACVRL1</i> ( <i>ALK1</i> ) Mutation

Barbara Girerd, David Montani, Florence Coulet et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 296 citations

Medicine, Cardiology, Genetics +13

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

Rogério Souza, Marc Humbert, Benjamin Sztrymf et al. · European Respiratory Journal · 2007 · 143 citations · Full text

Medicine, Cardiology, Pharmacology +14

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

David Launay, Olivier Sitbon, Jérôme Le Pavec et al. · Lara D. Veeken · 2009 · 106 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension

Bruno Degano, A. Yaïci, Jérôme Le Pavec et al. · European Respiratory Journal · 2008 · 103 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +15